{"id":"W2774243059","doi":"10.1016/j.ahj.2017.12.007","title":"The Optimal Anti-Coagulation for Enhanced-Risk Patients Post–Catheter Ablation for Atrial Fibrillation (OCEAN) trial","year":2017,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Ottawa; Hôpital du Sacré-Cœur de Montréal; McGill University Health Centre; Institut universitaire de cardiologie et de pneumologie de Québec; University Health Network; Libin Cardiovascular Institute of Alberta; Hamilton Health Sciences; Hotchkiss Brain Institute; University of Calgary; McMaster University; University of Toronto; Population Health Research Institute; Southlake Regional Health Center","funders":"Canadian Institutes of Health Research; Universiteit Hasselt; Biotronik; National Institute of Neurological Disorders and Stroke; Daiichi-Sankyo; Covidien; AstraZeneca; Bristol-Myers Squibb; Alberta Innovates - Health Solutions; Boston Scientific Corporation; F. Hoffmann-La Roche; Heart and Stroke Foundation of Canada; Pfizer; Abbott Laboratories; Bayer; Biosense Webster; Universiteit Antwerpen; Medtronic; Boehringer Ingelheim","keywords":"Medicine; Atrial fibrillation; Rivaroxaban; Stroke (engine); Randomized controlled trial; Internal medicine; Cardiology; Antithrombotic; Catheter ablation; Population; Interim analysis; Warfarin; Surgery","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007283762,0.0006420004,0.001582422,0.0001194336,0.0001683746,0.0009692443,0.0003481267,0.0006962804,0.003230933],"category_scores_gemma":[0.002040319,0.0002197201,0.001435038,0.0001548239,0.0004609533,0.0007671261,0.000742539,0.002248332,0.0002999916],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003145771,"about_ca_system_score_gemma":0.0005792124,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006126439,"about_ca_topic_score_gemma":0.001257666,"domain_scores_codex":[0.9997227,0.0001519346,0.00002038449,0.00003509078,0.0000164215,0.00005343337],"domain_scores_gemma":[0.999368,0.0002113931,0.0001700272,0.00006846143,0.00002404554,0.0001580276],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8705784,0.003281546,0.03872316,0.002074522,0.007316734,0.0003023595,0.0001513399,0.002327866,0.003754857,0.003020125,0.008112697,0.0603563],"study_design_scores_gemma":[0.7809402,0.03987937,0.1412535,0.0008245397,0.0156364,0.0004654367,0.0003629749,0.002700649,0.0009287917,0.007353986,0.009549139,0.0001050186],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9833847,0.007424112,0.0004935169,0.002405033,0.0005168596,0.0001993958,0.0008900154,0.00003850692,0.004647916],"genre_scores_gemma":[0.9867078,0.004311091,0.001289956,0.00259498,0.0008451102,0.0004461622,0.001853083,0.00001919739,0.00193252],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003230933,"threshold_uncertainty_score":0.01080853,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04405206787669842,"score_gpt":0.3649469929112036,"score_spread":0.3208949250345052,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}